Bobur Kholikov/LinkedIn
Oct 7, 2025, 13:06
Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
Bobur Kholikov, Regional Sales Manager at YHLO, shared a post on LinkedIn:
”iFlash Thrombosis Panel – D-Dimer
D-Dimer is a key biomarker of fibrin degradation, widely used to rule out or confirm thrombosis-related conditions. Elevated levels indicate active clot formation and breakdown, making it a crucial marker in emergency and routine care.
Clinical Value
- Excludes venous thromboembolism (VTE) with high negative predictive value
- Supports diagnosis of DVT, PE, and DIC
- Monitoring of anticoagulant therapy effectiveness
With the iFlash Thrombosis Panel, YHLO provides clinicians with reliable insights into coagulation and fibrinolysis, enhancing early intervention and improving patient outcomes.
Together, make a difference.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly